JARID2 and breast carcinoma: However, reduced expression of ARID1A (p=0.0265), ARID5B (p=0.0021), JARID1D (p=0.0223) and elevated expression of JARID2 (p=0.0125) were associated with poor OS in wild-p53-type breast cancer patients.